Intellectual property protection and high quality development of Radix Glycyrrhizae for treatment of COVID-19

ABSTRACT

Radix Glycyrrhizae is the dominant native medicinal material variety in the north and northwestern medicinal materials producing areas. It is a main Chinese medicine of effective TCM drugs and formulas for the treatment of new coronavirus disease(COVID-19). This paper introduces the medicinal value of Radix Glycyrrhizae, involving the labeling, cultural heritage, and creative intellectual property rights of the Chinese medicinal materials, analyzes the poverty-stricken areas that are ecologically suitable for Radix Glycyrrhizae cultivation, and the superior counties and production bases of the Chinese medicinal materials. Besides, mainly from the aspects of perfect intellectual property rights, the establishment of authentic medicinal material production bases, and the construction of quality control systems, etc., it discusses the rural revitalization strategy and the development strategy of traditional Chinese medicine(TCM), agricultural intellectual property protection and high-quality development strategy of Radix Glycyrrhizae.